Tompong, Mary Jean .

HRN: 21-51-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
CEFUROXIME 1.5GM (VIAL)
06/30/2022
07/07/2022
IVTT
1.5g
Q8hrs
S/P LTCS MSAF
Waiting Final Action 
06/30/2022
METRONIDAZOLE 500MG (TAB)
06/30/2022
07/07/2022
ORAL
500mg
TID
S/P LTCS MSAF
Waiting Final Action 
07/01/2022
CEFUROXIME 500MG (TAB)
07/01/2022
07/07/2022
PO
500ng
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: